Ying Jian
Impact in
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus
- Clostridium difficile and Clostridium perfringens research
- Clinical Biochemistry top 10%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antimicrobial Resistance in Staphylococcus 15
- Clostridium difficile and Clostridium perfringens research 4
-
- Bacterial biofilms and quorum sensing 11
- Co-authors
- Qian Liu (19 shared papers)Min Li (13 shared papers)Yao Liu (7 shared papers)Huiying Lv (5 shared papers)Xiaonan Dong (5 shared papers)Na Zhao (11 shared papers)Lin Zhao (5 shared papers)Lei He (6 shared papers)
- Journals
- Emerging Microbes & Infections (4 papers)Frontiers in Microbiology (3 papers)Journal of Antimicrobial Chemotherapy (2 papers)Communications Biology (2 papers)Advanced Healthcare Materials (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Ying Jian
46 papers receiving 505 citations
Peers
Comparison fields: 5 of 90
- Infectious Diseases 183
- Clinical Biochemistry 42
- Molecular Medicine 26
- Applied Microbiology and Biotechnology 9
- Critical Care and Intensive Care Medicine 19
Countries citing papers authored by Ying Jian
This map shows the geographic impact of Ying Jian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Jian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Jian more than expected).
Fields of papers citing papers by Ying Jian
This network shows the impact of papers produced by Ying Jian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Jian. The network helps show where Ying Jian may publish in the future.
Co-authors
The 25 scholars most cited alongside Ying Jian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 40 | |
| 2 | 2020 | 40 | |
| 3 | 2005 | 39 | |
| 4 | 2023 | 31 | |
| 5 | 2020 | 28 | |
| 6 | 2015 | 27 | |
| 7 | 2022 | 25 | |
| 8 | 2020 | 20 | |
| 9 | 2023 | 19 | |
| 10 | 2020 | 18 | |
| 11 | 2021 | 16 | |
| 12 | 2023 | 15 | |
| 13 | 2023 | 15 | |
| 14 | 2019 | 15 | |
| 15 | 2024 | 14 | |
| 16 | 2022 | 14 | |
| 17 | 2022 | 12 | |
| 18 | 2021 | 11 | |
| 19 | 2023 | 10 | |
| 20 | 2021 | 10 |
About Ying Jian
Ying Jian is a scholar working on Infectious Diseases, Molecular Biology, Epidemiology, Public Health, Environmental and Occupational Health and Critical Care and Intensive Care Medicine, having authored 47 papers that have together received 513 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (15 papers), Bacterial biofilms and quorum sensing (11 papers), Clostridium difficile and Clostridium perfringens research (4 papers), Pneumonia and Respiratory Infections (3 papers), Bacterial Identification and Susceptibility Testing (3 papers), Animal Disease Management and Epidemiology (3 papers), Nosocomial Infections in ICU (3 papers) and HIV Research and Treatment (3 papers). The work is most often cited by research in Infectious Diseases (183 citations), Clinical Biochemistry (42 citations), Molecular Medicine (26 citations), Applied Microbiology and Biotechnology (9 citations) and Critical Care and Intensive Care Medicine (19 citations). Ying Jian has collaborated with scholars based in China and United States. Frequent co-authors include Qian Liu, Min Li, Yao Liu, Huiying Lv, Xiaonan Dong, Na Zhao, Lin Zhao, Lei He, Ying-Hua Chen and Qian Huang. Their work appears in journals such as Emerging Microbes & Infections, Frontiers in Microbiology, Journal of Antimicrobial Chemotherapy, Communications Biology and Advanced Healthcare Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.